A recent study reported that one linear short peptide, which could selectively bind to the HPV16 E6 oncoprotein, restored the expression of functional p53 protein and specifically killed HPV16-positive cervical cancer cells by inducing apoptotic cell death (Celegato et al., 2020). The gene discussed is TP53; the disease is cervical carcinoma.